TORONTO, ONTARIO--(Marketwired - March 6, 2017) - Asian Mineral Resources Limited ("AMR" or the "Company") (TSX VENTURE:ASN) is pleased to announce that all resolutions presented before the Company's shareholders at the Annual & Special Meeting held March 6, 2017, including...Read More
TORONTO, ONTARIO--(Marketwired - March 22, 2017) - Asian Mineral Resources Limited ("AMR" or the "Company") (TSX VENTURE:ASN) is pleased to announce changes to the management and Board of the company. The changes to the management and Board are designed to reposition the company...Read More
TORONTO, ONTARIO--(Marketwired - April 7, 2017) - Asian Mineral Resources Limited ("AMR") (TSX VENTURE:ASN) has today granted stock options to its Chief Executive Officer, Duncan Blount, as follows: i) fifteen million options exercisable at Cdn $0.05 per share; ii) fifteen mi...Read More
TORONTO, ONTARIO--(Marketwired - April 24, 2017) - Asian Mineral Resources Limited ("AMR" or the "Company") (TSX VENTURE:ASN) is pleased to announce that it has entered into a net smelter royalty return agreement (the "NSR Agreement") with Cobalt 27 Capital Corp. ("Cobalt 27") re...Read More
TORONTO, ONTARIO--(Marketwired - May 10, 2017) - Ascendant Resources Inc. (TSX VENTURE:ASND) ("Ascendant" or the "Company") is very pleased to announce that Mr. Renaud Adams, P. Eng will stand for election to the Company's Board of Directors at the upcoming Annual and Specia...Read More
COPENHAGEN, Denmark, May 11, 2017 /PRNewswire/ -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced that the company will hold a conference call and live web...Read More
TORONTO, ONTARIO--(Marketwired - May 16, 2017) - Ascendant Resources Inc. (TSX VENTURE:ASND) ("Ascendant" or the "Company") is very pleased to announce that Mr. Guillermo Kaelin will stand for election to the Company's Board of Directors at the upcoming Annual and Special Me...Read More
COPENHAGEN, Denmark, May 23, 2017 /PRNewswire/ -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced financial results for the quarter ended March 31, 2017....Read More
EL MOCHITO, HONDURAS--(Marketwired - June 12, 2017) - Low availability and utilization rates for aging mobile equipment impacted production; new equipment arrivals currently underway Ascendant Resources Inc. (TSX VENTURE:ASND) ("Ascendant" or the "Company") announces...Read More